Loading
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Latest filing published 11 Sept 2026 for Barinthus Biotherapeutics plc., €840k.
Filing timeline
BuySaleOxford Science Enterprises plc
Insider track record
Disclosed buys
2
Disclosed sells
0
T+90 hit rate
100%
T+90 mean return
+28.1%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Oxford Science Enterprises plc: trading record in brief
Filings by Oxford Science Enterprises plc span 2 companies, the busiest being PepGen Inc. and Vaccitech plc. The record holds 6 filings, for trades running from 10 May 2022 to 9 September 2026.
The open-market record is one-sided, with 2 purchases worth €10.6M and not one sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.
The record was last updated on 11 September 2026 with a transaction (€840k) in Vaccitech plc. The last purchase on record was published on 1 October 2025, which is 389 days ago. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Oxford Science Enterprises plc
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations4 total
8,797,770 shares@ US$0.111100.0% of flowOrdinary SharesSEC:0001856079-26-000002:0
200,000 shares@ US$3.205.2% of flowCommon StockSEC:0001856079-25-000003:0
Canonical exit: 29 Dec 2025 (T+90)
879,970 shares@ US$12.00100.0% of flowCommon StockSEC:0000950170-24-043058:0
Canonical exit: 8 Aug 2022 (T+90)
1,262,986 shares0Common StockSEC:0000899243-22-017488:0
4 of 4 declarations
